From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Sep 17, 2003
MDL Docket No. 1290(TFH) Misc. No. 99ms276, Case No. 01-2646 (TFH), Case No. 02-1299 (TFH) (D.D.C. Sep. 17, 2003)

Opinion

MDL Docket No. 1290(TFH) Misc. No. 99ms276, Case No. 01-2646 (TFH), Case No. 02-1299 (TFH)

September 17, 2003


ORDER


Upon motion of Defendants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. to permit Michael R. Plummer, Esquire of the Pennsylvania Bar to appear and participate pro hac vice in this matter before the Court, it is hereby ORDERED that the motion be, and hereby is, GRANTED

SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Sep 17, 2003
MDL Docket No. 1290(TFH) Misc. No. 99ms276, Case No. 01-2646 (TFH), Case No. 02-1299 (TFH) (D.D.C. Sep. 17, 2003)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION This Applies to the…

Court:United States District Court, D. Columbia

Date published: Sep 17, 2003

Citations

MDL Docket No. 1290(TFH) Misc. No. 99ms276, Case No. 01-2646 (TFH), Case No. 02-1299 (TFH) (D.D.C. Sep. 17, 2003)